Uncategorised - European Medical Journal

Continue
EMJ
6 Jul 2015

Gene Regulates Stem Cells in Muscle Regeneration

PROTEIN called Prmt5 is key to the regulation of the activity and function of muscle stem cells in injured skeletal muscles, as revealed by researchers…
3 Jul 2015

SABRINA: Phase 3 study comparing subcutaneous and intravenous rituximab in follicular lymphoma

An update on the safety results of the phase 3 SABRINA study, which is comparing subcutaneous and intravenous rituximab in the maintenance setting of patients with follicular lymphoma.
3 Jul 2015

Subgroup analysis of the MCL-002 (SPRINT) trial of lenalidomide in relapsed/refractory MCL

At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses the…
3 Jul 2015

Ongoing studies by the German CLL study group (GCLLSG)

At the 20th Congress of the European Hematology Association (EHA), Barbara Eichhorst, MD, of the University of Cologne, Cologne, Germany, discusses…
3 Jul 2015

HELIOS: Phase 3 trial of ibrutinib in previously treated CLL/SLL

At the 20th Congress of the European Hematology Association (EHA), Paula Cramer, MD, of the University Hospital Cologne, Cologne, Germany, discusses the…
EMJ
3 Jul 2015

STELARA® Receives European Commission Approval for Treatment of Adolescents with Moderate-To-Severe Psoriasis in Europe

Beerse, Belgium, 29 June 2015 – Janssen-Cilag International NV (“Janssen”) announced today that the European Commission (EC) has approved STELARA®…
EMJ
3 Jul 2015

Animation Demonstrating Implantation of the CARILLON Device

Treatment of Secondary Mitral Regurgitation via Percutaneous Annuloplasty
EMJ
3 Jul 2015

Video of Patient Case Showing Real-Time Implantation of the CARILLON Device

Treatment of Secondary Mitral Regurgitation via Percutaneous Annuloplasty: Video of Patient Case Showing Real-Time Implantation of the CARILLON Device.
EMJ
3 Jul 2015

Studies Confirm Regorafenib Benefit in Pre-Treated Metastatic Colorectal Cancer

BARCELONA-LUGANO, 3 July 2015 – The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated…
EMJ
2 Jul 2015

Patients with Lowest BMI Have Shortest Survival in Pooled Analysis of Bevacizumab in Metastatic Colorectal Cancer

BARCELONA-LUGANO, 1 July 2015 – Patients with the lowest body mass index (BMI) had the shortest overall survival in an analysis of bevacizumab studies